Back
Regeneron Pharmaceuticals Stock Predictions
Sponsored
REGN
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
828.36
Seasonality Move:
11.8%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Regeneron Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 29.8% based on the past 33 years of stock performance.
- Regeneron Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
-
Is Regeneron Pharmaceuticals Stock Undervalued?
The current Regeneron Pharmaceuticals [REGN] share price is $828.42. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal. - REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 29.8% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
- Regeneron Pharmaceuticals has risen higher in 19 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.58%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
783.57
Prediction Charts
Market Cap:
91.03B
Price in USD:
828.42
Volume:
554.13K
Beta:
0.96
Technical Analysis
SMA50:
1,025.36
SMA100:
1,061.63
SMA200:
1,010.07
52-Wk Change:
0.68%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?
Yes, Regeneron Pharmaceuticals is a publicly traded company. -
What is the Regeneron Pharmaceuticals stock quote today?
The Regeneron Pharmaceuticals stock price is 828.42 USD today. -
How to buy Regeneron Pharmaceuticals stock online?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-22 | 963.00 | 962.34 | 972.75 | 919.42 |
Oct-23 | 951.80 | 941.39 | 959.60 | 932.53 |
Oct-24 | 945.71 | 928.90 | 952.02 | 928.50 |
Oct-25 | 930.23 | 933.02 | 943.83 | 930.23 |
Oct-28 | 934.78 | 928.61 | 943.27 | 927.20 |
Oct-29 | 927.20 | 927.33 | 932.38 | 923.75 |
Oct-30 | 919.73 | 922.79 | 935.86 | 914.85 |
Oct-31 | 875.00 | 838.21 | 883.15 | 815.99 |
Nov-1 | 844.61 | 843.60 | 862.00 | 837.88 |
Nov-4 | 845.59 | 828.87 | 852.01 | 826.76 |
Nov-5 | 824.94 | 829.43 | 836.63 | 819.14 |
Nov-6 | 844.51 | 816.65 | 844.51 | 813.53 |
Nov-7 | 817.88 | 824.48 | 832.53 | 814.05 |
Nov-8 | 826.57 | 828.42 | 830.73 | 822.80 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.57 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.